Loading
No insider purchase over the last 90 days. The latest was filed 08 Jun 2026.
DNL: what insiders have been doing
Every trade that managers of DNL disclose to ASX is tracked on this page. The company sits in the Chemicals sector. Over the twelve months to 18 October 2026, 4 filings were filed, from 3 insiders.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 senior executive among the declarants.
For context, the typical company on the same exchange (median of 2,527 companies) published 3 filings over the same period, against 4 filings here. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.
The last purchase on record was published on 8 June 2026, which is 131 days ago.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleGregory Robinson1 buy
Since the insiders bought
- +2.0%Entry A$3.83 · Close 15 Oct 2026 A$3.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate DNL Buy (bullish), based on 14 analysts. Average price target: A$3.86.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,729 of 24,161 companies
41.9
score / 100
Value38
Quality46
FCF yld1.4%
Earn yld-0.8%
EV/EBITDA14.4x
ROE5.8%
Gross mgn67%
Net mgn-1.4%
Debt/EBITDA3.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
A$4.01
Analyst consensus
14 analystsBuy
A$2.90Target A$3.86(-4%)A$4.42
Income statement
RevenueA$3.7B
Gross profitA$2.5B67% margin
EBITDAA$628.3M17% margin
Net income-A$53.2M-1.0% margin
Valuation
PER (trailing)28.6x
PER (forward)20.6x
P/Book1.7x
Beta0.41
Balance sheet & cash
Market capA$7B
Total debtA$2B
Free Cash FlowA$100.5M
Debt / Equity40%
Profitability & ownership
ROE5.8%
ROA5.0%
% insiders0.1%
% institutions56.6%
Last declaration on 30 September 2026
Declarations4 total
ShareASXASX:2924-03142608-3A703015
ShareASXASX:2924-03104033-3A695997
24,448 shares100.0% of flowShareASXASX:2924-03097984-3A694868
Canonical exit: 2 Sept 2026 (T+90)
ShareASXASX:2924-03086839-3A692726
4 of 4 declarations
About DNL
DNL is a company operating in the chemicals and materials sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
